Investors

Redbiotec is privately owned and backed by pharma-experienced institutional and private investors.
To find out more about investment opportunities with Redbiotec, please contact us.

Our current investors are:

Redalpine Capital I Swiss venture fund.
V+ GmbH & Co Fonds 2 KG German venture capital fund.
Zürcher Kantonalbank (ZKB Group) Switzerland’s largest cantonal bank. S&P: AAA Rating.

Backed by experienced private investors.